Supplementary Figure 3: Cell sensitivity assay after mitomycin C (MMC) treatment using the VTI system.

(a) The experimental scheme of cell sensitivity assay after MMC treatment. (b) Typical 96-well plate pattern for the assay and (c) cell sensitivity assay for normal 48BR, XP-CS-Fanconi-complex patients derived XPCS1CD and XP-CS-complex patients derived CS1USAU cells. Data in (c) were normalised to the EdU incorporation level measured in untreated cells. Data points and error bars represent average fluorescent intensities of quadruplicate wells and standard deviations, respectively.